Scott Wasserman
Net worth: - $ as of 31/10/2026
Net worth: - $ as of 31/10/2026
Scott M.
Wasserman is currently Chief Medical Officer at Kailera Therapeutics, Inc. since 2024 and Independent Director at Inhibikase Therapeutics, Inc. since 2026.
Formerly, Dr. Wasserman was Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023, Venture Partner at Frazier Management LLC from 2023 to 2024, and Vice President & Global Development at Amgen, Inc. from 2015 to 2019.
Education includes an undergraduate degree from Haverford College conferred in 1992 and an undergraduate degree from Stanford University School of Medicine conferred in 2004.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 16/04/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Companies | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 19/10/2026 |
| Companies | Position | End |
|---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Private Equity Investor | 01/10/2024 |
| LATIGO BIOTHERAPEUTICS, INC. | Chief Executive Officer | 01/06/2023 |
| AMGEN INC. | Private Equity Investor | 01/05/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions